- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Eye protection.
Displaying page 1 of 3.
EudraCT Number: 2013-002183-63 | Sponsor Protocol Number: IOBA-CERLab-003-2013 | Start Date*: 2013-11-12 | ||||||||||||||||
Sponsor Name:IOBA | ||||||||||||||||||
Full Title: Unicenter, double masked, crossover clinical trial to assess the efficacy of FML (0.1% Fluorometolone) in dry eye patients | ||||||||||||||||||
Medical condition: Dry eye syndrome (DES) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000913-35 | Sponsor Protocol Number: BECRO/OV/DORZO | Start Date*: 2019-05-21 | |||||||||||||||||||||
Sponsor Name:BECRO (Cyprus) Ltd | |||||||||||||||||||||||
Full Title: A Randomized, Observer-blind, two Parallel Group, Multi-center, Clinical Trial for Comparing the Efficacy and Tolerability of Dorzo-Vision® sine Preservative-Free Eye Drops vs. Trusopt® Preservativ... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000921-39 | Sponsor Protocol Number: PH-BRINLOL-01 | Start Date*: 2019-04-24 | |||||||||||
Sponsor Name:PHARMATHEN SA | |||||||||||||
Full Title: A prospective, phase III, multicenter, randomized, investigator-masked, parallel groups, non-inferiority clinical trial for the comparison of efficacy and safety and of a generic fixed combination ... | |||||||||||||
Medical condition: open-angle glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) CY (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001178-70 | Sponsor Protocol Number: BECRO/ACT/ORASIS-LT | Start Date*: 2023-01-26 | |||||||||||||||||||||
Sponsor Name:actrevo GmbH | |||||||||||||||||||||||
Full Title: Non-inferiority, Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic BAC-free Formulation of Latanoprost/Timolol 0.05 mg/mL +... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002910-29 | Sponsor Protocol Number: BECRO/PHN/LATANO | Start Date*: 2017-09-26 | |||||||||||||||||||||
Sponsor Name:PHARMATHEN | |||||||||||||||||||||||
Full Title: Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Preservative-Free Formulation ... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-004524-29 | Sponsor Protocol Number: BECRO/PHN/LATIM | Start Date*: 2018-02-28 | |||||||||||||||||||||
Sponsor Name:PHARMATHEN | |||||||||||||||||||||||
Full Title: Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Preservative-Free Formulation ... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000160-34 | Sponsor Protocol Number: BECRO/OV/BRIMTIM | Start Date*: 2015-06-29 | |||||||||||||||||||||
Sponsor Name:OmniVision GmbH | |||||||||||||||||||||||
Full Title: Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Formulation of 0.2% Brimonidin... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002576-91 | Sponsor Protocol Number: Becro/OV/Travoprost | Start Date*: 2014-09-30 | |||||||||||||||||||||
Sponsor Name:OmniVision GmbH | |||||||||||||||||||||||
Full Title: Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Formulation of Travoprost 40μg... | |||||||||||||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-000982-19 | Sponsor Protocol Number: IOBA-ImmunEyez_011-2018 | Start Date*: 2019-12-11 |
Sponsor Name:Instituto de Oftalmobiología Aplicada (IOBA) | ||
Full Title: A Phase IV Open-Label Clinical Trial to Evaluate the Efficacy of Ikervis® on Clinical Parameters and Molecular/Cellular Biomarkers in Dry Eye Patients with Severe Keratitis who have not improved de... | ||
Medical condition: Dry eye disease with severe keratitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003677-66 | Sponsor Protocol Number: RESTORE | Start Date*: 2022-02-14 | |||||||||||
Sponsor Name:Amsterdam University Medical Center | |||||||||||||
Full Title: Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis | |||||||||||||
Medical condition: Multiple sclerosis (MS) Internuclear ophthalmoparesis (INO) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003597-26 | Sponsor Protocol Number: 1698-302-007 | Start Date*: 2019-11-07 | ||||||||||||||||
Sponsor Name:Allergan Ltd. | ||||||||||||||||||
Full Title: An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-angle Glaucoma and Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) AT (Prematurely Ended) DE (Ongoing) BE (Completed) ES (Ongoing) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000946-24 | Sponsor Protocol Number: 15-EI-0202 | Start Date*: 2018-01-09 |
Sponsor Name:National Eye Institute | ||
Full Title: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration | ||
Medical condition: Geographic Atrophy Associated with Age-Related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003029-40 | Sponsor Protocol Number: IOBA-01-2016 | Start Date*: 2017-02-14 |
Sponsor Name:IOBA - University of Valladolid | ||
Full Title: Phase II safety assessment of intravitreal injection of mesenchymal stem cells for acute non arteritic anterior ischemic optic neuropathy (NAION) | ||
Medical condition: Non arteritic anterior ischemic optic neuropathy (NAION) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021507-24 | Sponsor Protocol Number: 192024-050 | Start Date*: 2011-02-23 | |||||||||||||||||||||
Sponsor Name:Allergan Limited | |||||||||||||||||||||||
Full Title: A Multicenter, Double-masked, Randomized, Parallel Study of the Safety and Efficacy of Bimatoprost 0.03%/Timolol 0.5% Preservative freeOphthalmic Solution Compared with GANFORT® (bimatoprost 0.03%/... | |||||||||||||||||||||||
Medical condition: Glaucoma or Ocular Hypertension | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) HU (Completed) CZ (Completed) GB (Completed) ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002574-52 | Sponsor Protocol Number: 1698-301-007 | Start Date*: 2019-08-01 | ||||||||||||||||
Sponsor Name:Allergan Ltd. | ||||||||||||||||||
Full Title: A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Trial now transitioned) IE (Trial now transitioned) SE (Completed) CZ (Trial now transitioned) HU (Completed) PL (Trial now transitioned) DK (Trial now transitioned) BG (Trial now transitioned) IT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005339-15 | Sponsor Protocol Number: QTM/OMN0211 | Start Date*: 2012-02-03 | ||||||||||||||||
Sponsor Name:Omnivision GmbH | ||||||||||||||||||
Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of the Fixed Combin... | ||||||||||||||||||
Medical condition: Primary open angle glaucoma or intraocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-012304-55 | Sponsor Protocol Number: 192024-038 | Start Date*: 2009-07-15 | |||||||||||
Sponsor Name:Allergan Ltd | |||||||||||||
Full Title: A One Year, Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost 0.03% Solution Compared to Vehicle to Treat Hypot... | |||||||||||||
Medical condition: Hypotrichosis of the eyelashes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005314-29 | Sponsor Protocol Number: QTM/OMN-0115 | Start Date*: 2016-03-02 |
Sponsor Name:OMNIVISION GmbH | ||
Full Title: Randomized, open-label, two parallel group clinical trial, conducted under blinding evaluator conditions to compare the efficacy and tolerability of preservative-free formulation of Latanoprost 50µ... | ||
Medical condition: Open Angle Glaucoma or Ocular Hypertension | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-002496-17 | Sponsor Protocol Number: 206207-008 | Start Date*: 2006-03-08 |
Sponsor Name:Allergan Limited | ||
Full Title: A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Seg... | ||
Medical condition: Macular Oedema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000026-22 | Sponsor Protocol Number: QTM/OMN0112 | Start Date*: 2012-07-23 | ||||||||||||||||
Sponsor Name:Omnivision GmbH | ||||||||||||||||||
Full Title: Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of Travoprost 40 µg... | ||||||||||||||||||
Medical condition: Primary open angle glaucoma or intraocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
